Assignment Instructions/ Description
Wk 2 Discussion 2 � Evaluating Investments and Capital Expenditures
Please refer to this week�s learning materials. They are intended to help you engage effectively in this discussion.
Write a 250- to 300-word response to the following:
Compare and contrast the 3 methods for evaluating investments and capital expenditures, such as how they apply to new projects, programs, and product launches:
Return on investment (ROI)
Net present value (NPV)
Internal rate of return (IRR)
Include your own experience as well as 2 citations that align with or contradict your comments as sourced from peer-reviewed academic journals, industry publications, books, or other sources. Cite your sources using APA formatting.
If you found contradicting information to what your experience tells you, explain why you agree or disagree with the research.
Review your classmates� posts. Respond to at least one of your colleagues in a post of at least 150 words. Explain why you agree or disagree with that post. Then, share an example from your professional experience to support your assertions.
Valuation: Measuring and Managing the Value of Companies, Ch. 29
Read Ch. 29, �: Analytics.�
Read Ch. 29, �Strategic Management: Analytics.�
Wk 2 Supplemental Materials
Review this week�s Supplemental Materials.
Review this week�s Supplemental Materials.
Financing Alternatives and Capital Structure Decisions
Calnan, C. (2017). Finding the right funding partners. Business NH Magazine, 34(10), 46.
Daks, M. (2018). Primed for growth: Initial funding can make difference. Njbiz, 31(29), 14.
Goodman, M. (2016). One bazillion potential shareholders. Entrepreneur, 44(7), 58-63.
Gould, M. (2018). Financing the corporation. Research Starters Business, 1.
Hall, J. (2018). Debt and equity: Two sides of mezzanine funding: This flexible financing option has earned its stripes in every kind of economic climate. McKnight�s Long-Term Care News, 16.
Loan away from home; Private debt in emerging markets. (2019, June 22). The Economist, 431(9148), 61.